New insights into developmental fate decisions by autoreactive CD4 thymocytes

Xuguang Tai , Alfred Singer

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (2) : e1590

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (2) : e1590 DOI: 10.1002/ctm2.1590
EDITORIAL

New insights into developmental fate decisions by autoreactive CD4 thymocytes

Author information +
History +
PDF

Cite this article

Download citation ▾
Xuguang Tai, Alfred Singer. New insights into developmental fate decisions by autoreactive CD4 thymocytes. Clinical and Translational Medicine, 2024, 14(2): e1590 DOI:10.1002/ctm2.1590

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Ashby KM, Hogquist KA. A guide to thymic selection of T cells. Nat Rev Immunol. 2024;24(2):103-117.

[2]

Singer A, Adoro S, Park JH. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat Rev Immunol. 2008;8(10):788-801.

[3]

Klein L, Robey EA, Hsieh CS. Central CD4(+) T cell tolerance: deletion versus regulatory T cell differentiation. Nat Rev Immunol. 2019;19(1):7-18.

[4]

Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol. 2006;6(2):127-135.

[5]

Tai X, Indart A, Rojano M, et al. How autoreactive thymocytes differentiate into regulatory versus effector CD4(+) T cells after avoiding clonal deletion. Nat Immunol. 2023;24(4):637-651.

[6]

Hemmers S, Schizas M, Azizi E, et al. IL-2 production by self-reactive CD4 thymocytes scales regulatory T cell generation in the thymus. J Exp Med. 2019;216(11):2466-2478.

[7]

Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol. 2005;6(2):152-162.

[8]

Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol. 2008;9(6):632-640.

[9]

Ouyang W, Beckett O, Ma Q, Li MO. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity. 2010;32(5):642-653.

[10]

Lio CW, Hsieh CS. A two-step process for thymic regulatory T cell development. Immunity. 2008;28(1):100-111.

[11]

Tai X, Erman B, Alag A, et al. Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity. 2013;38(6):1116-1128.

[12]

Luckey MA, Kimura MY, Waldman AT, Feigenbaum L, Singer A, Park JH. The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling. Nat Immunol. 2014;15(7):638-645.

[13]

Brugnera E, Bhandoola A, Cibotti R, et al. Coreceptor reversal in the thymus: signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells. Immunity. 2000;13(1):59-71.

[14]

Shinzawa M, Moseman EA, Gossa S, et al. Reversal of the T cell immune system reveals the molecular basis for T cell lineage fate determination in the thymus. Nat Immunol. 2022;23(5):731-742.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

120

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/